The first-in-class alkylating HDAC inhibitor EDO-S101 is highly synergistic with proteasome inhibition against multiple myeloma through activation of multiple pathways

Detalles Bibliográficos
Autores principales: Besse, L, Kraus, M, Besse, A, Bader, J, Silzle, T, Mehrling, T, Driessen, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549260/
https://www.ncbi.nlm.nih.gov/pubmed/28753594
http://dx.doi.org/10.1038/bcj.2017.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549260/
https://www.ncbi.nlm.nih.gov/pubmed/28753594
http://dx.doi.org/10.1038/bcj.2017.69

Ejemplares similares